Driving Digital in Biopharma

Accenture
  • ٥٫٠ (١٨)
  • طب
Driving Digital in Biopharma

An exploration of the digital trends and technology driving change in the biopharmaceutical industry. In-depth conversations with industry leaders at the forefront of transformation.

  1. ٤ ربيع الآخر

    Tech + AI & Data = Innovative medicine for patients

    In this insightful episode of Driving Digital in Biopharma, host Tom Lehmann explores with Áine Hanly, Chief Technology Officer at Vir Biotechnology, the transformative role of data and technology in drug development and manufacturing. Áine delves into the advancements in data accessibility and automation, such as single-cell manipulation and high throughput processes, which have notably shortened cycle times and boosted efficiency. She also discusses the innovative use of the Vir AI tool Daisy for antibody design and optimization, which speeds up the process and enhances manufacturability. The episode wraps up by highlighting the critical importance of a robust data strategy and the power of cross-functional partnerships in fostering innovation and operational efficiency across the biopharma industry.

    ٣٣ من الدقائق

  2. ١٣ ربيع الأول

    Inflection Point: Transforming Today’s Labs for the Future

    This episode of Driving Digital in Biopharma offers a peek into the digital revolution brewing in the biopharma labs, courtesy of Richard Milne, the Vice-president and general manager of Digital Science Solutions at Thermo Fisher Scientific. From e-commerce roots to pioneering digital science, Richard and Tom delve into the vision for laboratories, and the integration of artificial intelligence and automation in scientific research and lab operations. Their conversation highlights the critical role of digital strategies in enhancing productivity and accelerating scientific advancements. Richard also gives his insights on the future potential of automation and robotics in laboratories, alongside the challenges and opportunities that AI presents in revolutionizing the drug discovery process.

    ٤٥ من الدقائق

  3. ١٠ ذو الحجة

    Unlocking Growth: How Digital Innovation is Transforming Commercial Manufacturing

    In this episode of "Driving Digital in Biopharma," host Tom Lehmann welcomes Morrey Atkinson, the Chief Technology and Operations Officer at Vertex Pharmaceuticals. With a rich background in process development and manufacturing within the pharmaceutical industry, Morrey shares his insights on Vertex's strategic evolution and its commitment to serial innovation through substantial investments in R&D. They discuss the company’s modality-agnostic approach, which allows flexibility in tackling various diseases, as well as covering the strategic use of contract development and manufacturing organizations (CDMOs) to optimize Vertex's global manufacturing footprint, ensuring rapid and reliable delivery of therapies to patients worldwide.  Listeners will gain a comprehensive understanding of how Vertex Pharmaceuticals leverages digital innovation to maintain its leadership in drug development and manufacturing, setting new standards in the biopharma industry.

    ٣٤ من الدقائق

  4. ٢٦ شعبان

    Innovating Oncology Patient Experience with Data, Digital & Tech

    In this episode of the Driving Digital in Biopharma podcast, Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology, joins Tom Lehmann, Global Head of Accenture Life Sciences R&D, to discuss the role of digital in creating exceptional HCP and patient experiences. Through their shared passion for data and tech and the importance of using it to positively change not only the Life Sciences industry but also the lives of our loved ones, Samer and Tom explore how Takeda is leveraging data to create a meaningful impact on patients’ experiences. We glimpse into the actions Samer and his team are taking around the globe, discuss how their organizational structure and innovation mindset create the opportunity for agility, and explore real-life applications of technology to improve patient outcomes. Samer emphasizes the need to balance investment choices with business expectations and ultimately showcase the impact of those investments, while always keeping the patient at heart.

    ٣٣ من الدقائق

  5. ١٩‏/٠٤‏/١٤٤٥ هـ

    A modern balancing act: Harmonizing digital, data and traditional ways of working

    In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, speaks to Chris Braithwaite, Global Head of Drug Development, Digital and IT Novartis. Achieving digital transformation requires a delicate balance between traditional methods, rapidly emerging technology, and human decision-making. Chris encourages a shift in perspective and a focus on change management, emphasizing that working in a human+machine mode does not entail eliminating human roles. Instead, it involves developing comfort and knowledge regarding data and technology to enhance human potential and increase role effectiveness. By embracing digital tools and leveraging data, organizations can empower themselves to make informed decisions, drive adoption, and ultimately improve patient care.

    ٤٣ من الدقائق

  6. ٠٧‏/١٠‏/١٤٤٤ هـ

    Design for the future and deliver progress over perfection

    In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, talks with Michel Rider, VP Digital, Analytics and Performance at GSK. Michel reflects on their multi-year quest to modernize digital, data, and analytics capabilities across Development – sharing insights for achieving near-term wins while planning for the future. There is a sense of urgency for patients seeking better, faster treatments. And this is a non-linear endeavor – iteration and evolution are a given. A compressed transformation approach combined with agile experimentation can deliver tangible benefits quickly and establish a foundation for future growth.

    ٤٢ من الدقائق

  7. ٠٨‏/٠٨‏/١٤٤٤ هـ

    Rethink it: Digital is not a thing, digital is a means

    In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital.  When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data present complex challenges, a strong digital core will fuel competitive advantages.

    ٤٨ من الدقائق

  8. ٠٥‏/٠٥‏/١٤٤٤ هـ

    2022 Life Sciences Tech Trends - The Metaverse Continuum for Supply Chain

    In this episode, Tom Lehmann talks with Natasha Kelly, a data scientist within Accenture's Applied Intelligence Group who focuses on advanced analytic solutions in life sciences manufacturing and supply chain. Tom and Natasha discuss the 2022 Life Sciences Technology Vision through a supply chain lens, delving into how each of the report's four trends ingrained in the metaverse are reshaping supply chain and operations experiences across the industry.

    ٢٣ من الدقائق
مشاهدة الكل (٢٩)

التقييمات والمراجعات

٥
من ٥
‫١٨ من التقييمات‬

حول

An exploration of the digital trends and technology driving change in the biopharmaceutical industry. In-depth conversations with industry leaders at the forefront of transformation.

المعلومات

  • صناع العمل
    Accenture
  • سنوات النشاط
    ١٤٤١ هـ - ١٤٤٦ هـ
  • الحلقات
    ٢٩
  • التقييم
    ملائم
  • حقوق النشر
    © 2021 Accenture. All rights reserved.
  • موقع البرنامج على الويب
    Driving Digital in Biopharma

المزيد من Accenture

قد يعجبك أيضًا

للاستماع إلى حلقات ذات محتوى فاضح، قم بتسجيل الدخول.

اطلع على آخر مستجدات هذا البرنامج

قم بتسجيل الدخول أو التسجيل لمتابعة البرامج وحفظ الحلقات والحصول على آخر التحديثات.
تحديد بلد أو منطقة

أفريقيا والشرق الأوسط، والهند

آسيا والمحيط الهادئ

أوروبا

أمريكا اللاتينية والكاريبي

الولايات المتحدة وكندا